Skip to main content
logo
Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
4.101
-0.179 (-4.18%)
Oct 23, 2026, 11:51 AM EDT - Market open

Adicet Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----24.999.73
Revenue Growth
----156.83%-45.65%
Gross Profit
----24.999.73
Operating Income
-103.71-122.11-127.62-132.58-72.55-60.24
Net Income
-98.97-116.8-117.12-142.66-69.79-62
Earnings Per Share
-10.52-16.95-21.33-53.03-27.18-32.05
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
118.19158.53176.3159.71257.66277.54
Total Debt
12.8514.7417.2320.9221.0220.94
Net Cash (Debt)
105.34143.79159.07138.79236.63256.6
Net Cash Growth
-3.90%-9.60%14.61%-41.35%-7.78%251.63%
Net Cash Per Share
11.2020.8728.9751.5992.16132.64

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-84.53-95.25-92.38-93.72-44.77-51.05
Capital Expenditures
-0.44-1.74-1.12-4.46-16.78-13.05
Free Cash Flow
-84.97-96.98-93.5-98.18-61.55-64.1
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----100.00%100.00%
Operating Margin
-----290.32%-619.15%
Pretax Margin
-----279.27%-638.48%
Profit Margin
-----279.27%-637.19%
FCF Margin
-----246.29%-658.77%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----15.3370.36